Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Motor Activity 9Breast Neoplasms 7Neoplasms 4Fatigue 3Recurrence 2Body Weight 2Weight Loss 1Warts 1Vomiting 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Neoplasm Metastasis 1Nausea 1Multiple Myeloma 1Lymphoma, Follicular 1Lymphoma 1Lung Neoplasms 1Leukemia 1Insulin Resistance 1Hodgkin Disease 1Hematologic Neoplasms 1Hematologic Diseases 1Head and Neck Neoplasms 1Dementia 1Colonic Neoplasms 1Cognitive Dysfunction 1Asthenia 1Anomia 1Alzheimer Disease 1

Interventions

pirtobrutinib 5Lenalidomide 4Rituximab 3Imatinib Mesylate 3ruxolitinib 2ponatinib 2ibrutinib 2Platelet Transfusion 2Brentuximab Vedotin 2Bortezomib 2Bendamustine Hydrochloride 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2zanubrutinib 1vosaroxin 1venetoclax 1nilotinib 1idelalisib 1bosutinib 1acalabrutinib 1Zoledronic Acid 1Vorinostat 1Vincristine 1Tretinoin 1Prednisone 1Plasma Exchange 1Granulocyte-Macrophage Colony-Stimulating Factor 1Exercise 1Doxorubicin 1Dexamethasone 1Denosumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Hematologic Diseases × Exercise × Clear all
NCT00884364 2009-12-23

Exercise During Chemotherapy for Patients With Hematological Malignancies

Charite University, Berlin, Germany

Phase 3 Unknown
60 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Fatigue, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Motor Activity, Multiple Myeloma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡